Causes of Obesity
Causes of Obesity
In general mankind, since the improvement of cookery, eats twice as much as nature requires.
—Benjamin Franklin,
American scientist, publisher, and diplomat There is a simple equation that explains how a person’s body maintains its weight. To maintain a steady body weight, the amount of energy a person takes in (the number [...]
SOCIAL ISSUES ASSOCIATED WITH OBESITY
SOCIAL ISSUES ASSOCIATED WITH OBESITY
SOCIAL ISSUES ASSOCIATED WITH OBESITY
Anyone who has watched an episode of Friends or The OC has seen the glorified ideal of being thin; the characters are extremely thin and ultimately many people who watch the show are inclined to want to lose weight, even if they do so [...]
Diet Drug Acomplia Sales Disappoint; No Major Improvement Seen Until 2009
Sales of diet drug Acomplia (rimonabant) , available in Europe but not approved in the U.S., have turned into a major disappointment for Sanofi-Aventis, which says it does not expect the situation to significantly improve until new clinical trial results are ready for submission to regulators in [...]
Sanofi to Present More Acomplia Data at April 11th Meeting
Sanofi-Aventis, developer of the highly publicized anti–obesity drug Acomplia, will present new data on the drug’s role in reducing metabolic cardiovascular disease risk factors at a scientific meeting in San Diego April 11th and 12th.
Dr. Pierre Rosenzweig, a Vice President of Sanofi-Aventis, will make the presentation at the Annual Metabolic [...]
Report in The Lancet Further Boosts Interest in Weight-Loss Drug Acomplia
A report published in this week’s issue of the prestigious medical journal, The Lancet, further stoked interest in the promising new weight-loss drug Acomplia (rimonabant) but in fact provided little new information.
The report was based on one-year results from the RIO–Europe clinical trial, which showed [...]
Diet Pills: The Future
Diet Pills: The Future’
The quest for the perfect weight loss drug continues as the prevalence of obesity in the United States and other industrialized
countries rises.Why has it been so difficult for drug manufacturers to develop the “perfect” diet pill? One reason is that the causes of obesity are not [...]
Support for “Metabolic Syndrome” May Buttress Expanded Role for Acomplia
The American Heart Association (AHA) and the National Heart, Lung and Blood Institute (NHLBI) on Sept. 13 issued a new scientific statement taking issue with two major diabetes organizations Acomplia (rimonabant) that a month ago questioned the validity of diagnosing patients with “metabolic syndrome.”
The debate could well impact efforts of [...]
FDA Advisory Panel Says Obese Kids Should Be Included in Drug Trials
A U.S. FDA Advisory Committee reviewing guidelines for weight-loss drug trials appear prepared to call for studies that focus on the effect of anti–obesity drugs on severely obese children Acomplia (rimonabant) .
Acomplia (rimonabant) “This population of patients needs to be studied separately from the [...]
